You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: April 25, 2024

Claims for Patent: 7,154,025


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 7,154,025
Title:Method for obtaining plants exhibiting enhanced resistance to water stress
Abstract: A method for obtaining a plant having a modified amount of ASR protein, providing it with enhanced resistance to water stress compared to a non-transformed plant, comprises: transforming at least a plant cell with a vector, containing an expression cassette including a nucleotide sequence coding for an ASR protein or inhibiting the expression of an ASR protein; culturing the resulting transformed cell so as to generate a plant containing in its genome the expression cassette.
Inventor(s): Zivy; Michel (Paris, FR), Perez; Pascual (Chanonat, FR)
Assignee: Biogemma (Paris, FR) Institut National de la Recherche Agronomique (Paris, FR) Association Generale des Producteurs de Mais Technique (Montardon, FR)
Application Number:10/258,521
Patent Claims:1. A method for obtaining a transformed plant exhibiting an increased amount of ASR (ABA-water stress-ripening-induced) protein, conferring on said plant increased resistance to water deficit stress compared to a non-transformed plant, comprising transforming at least one plant cell with a vector containing an expression cassette comprising a nucleotide sequence encoding an ASR protein, wherein said ASR protein comprises the amino acid sequence of SEQ ID NO: 2; and culturing the cell thus transformed so as to generate a plant containing, in its genome, said expression cassette, and wherein said plant expresses said protein.

2. The method according to claim 1, wherein said nucleotide sequence encoding said ASR protein comprises sequence SEQ ID No 1.

3. The method according to claim 1, wherein the expression cassette comprises a promoter for constitutive expression of the nucleotide sequence encoding the ASR protein.

4. A plant, or plant part comprising a nucleotide sequence encoding the amino acid sequence of SEQ ID NO: 2, wherein said plant or plant part is obtained by the method of claim 1.

5. The plant, or part of a plant, according to claim 4, that exhibits an increase in expression of the ASR protein compared to a non-transformed plant.

6. The plant, or part of a plant, according to claim 4, which is a field crop plant selected from maize, wheat, rapeseed, sunflower and peas.

7. The plant, or part of a plant, according to claim 4, which is maize.

8. The method according to claim 3, wherein said promoter is a rice actin promoter operably linked to a rice actin gene intron.

Details for Patent 7,154,025

Applicant Tradename Biologic Ingredient Dosage Form BLA Approval Date Patent No. Expiredate
Merck Sharp & Dohme Corp. INTRON A interferon alfa-2b For Injection 103132 06/04/1986 ⤷  Try a Trial 2020-04-28
Merck Sharp & Dohme Corp. INTRON A interferon alfa-2b For Injection 103132 ⤷  Try a Trial 2020-04-28
Merck Sharp & Dohme Corp. INTRON A interferon alfa-2b Injection 103132 ⤷  Try a Trial 2020-04-28
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Approval Date >Patent No. >Expiredate

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.